Cure My Disease

Don't miss your cure!

 Log in / Sign up

Daily vitamin pills may sharpen teen minds and strengthen bones, large trial tests

NCT ID NCT07695883

Disease control Sponsor: Johns Hopkins Bloomberg School of Public Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Sep 04, 2026 · Updated 5 times

Summary

This trial tests whether giving adolescent girls a daily multiple micronutrient supplement (with or without extra nutrients) improves their growth, brain function, bone health, and overall well-being compared to the standard weekly iron-folic acid pill. About 3,000 girls aged 10–18 in rural Bangladesh will take the supplements for one year. The goal is to see if a simple daily pill can help teens in low-resource settings reach their full potential.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multiple micronutrient supplement (UNIMMAP formulation) with or without additional nutrients
What this could lead to
If effective, daily multiple micronutrient supplements could become a standard policy to improve growth, learning, and bone health in adolescent girls in low-resource settings.
What could go wrong
This is a single trial in one rural area of Bangladesh, so results may not apply elsewhere. Supplements may not show clear benefits over weekly iron-folic acid, and side effects from high-dose nutrients are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 3,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 18 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Unmarried 10-18 year old females * living in their parental home in the study area Exclusion Criteria: * Married females under 18 years old; * those with a history or diagnosis of chronic or congenital heart disease, chronic kidney or lung disease, cancer, and epilepsy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blood pressure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary endocrine growth disease hypertensive disorder neurodevelopmental disorder Thinness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Blood pressure Body composition Bone mineral density Hrqol (health related quality of life) Linear growth Micronutrient status Neurodevelopment outcome Stunting Underweight Waist-to-height ratio

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • JiVitA Project Head Quarters

    Rangpur City, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.